Clinical Trials › NCT06796504
RecruitingNA
The SetPoint System as a Pro-Remyelination Therapy for Relapsing-Remitting Multiple Sclerosis: A Pilot Study
Sponsored by SetPoint Medical Corporation
Interested in joining? Eligibility criteria and contact info are on ClinicalTrials.gov.
View on ClinicalTrials.gov 60
Target enrollment
4
U.S. states
Mar 2026
Start date
Sep 2030
Expected completion
Interventions / Treatments
Procedure/Surgery: Implant ProcedureDisease-Modifying Therapies (DMTs)Device: Active stimulationDevice: Non-active stimulation
Conditions studied
Relapsing Remitting Multiple Sclerosis
Where this trial is running (4 sites)
Participating MS centers on MS Buddy (3)
UW Medicine Multiple Sclerosis Center
Seattle, WA
Seattle, WA
The Minnesota Center for MS
Plymouth, MN
Plymouth, MN
Andrew C. Carlos MS Institute at Shepherd
Atlanta, GA
Atlanta, GA
MS centers in Georgia
Compare treatment centers near a trial site by center type, providers and trials.
View Georgia centers